Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J J Scarisbrick

Showing results (1-10 of 52) with videos related to

Pageof 6
Sort By:
Clinical and Experimental Dermatology|February 21, 2006
Staging and management of cutaneous T-cell lymphomaJ J Scarisbrick
The British Journal of Dermatology|January 10, 2018
Brentuximab vedotin is an effective therapy for CD30<sup>+</sup> mycosis fungoides and cutaneous anaplastic large-cell lymphoma: what is the cost?J J Scarisbrick
The British Journal of Dermatology|August 4, 2016
Cutaneous T-cell lymphomas: an urgent need for more improved therapiesJ J Scarisbrick
The British Journal of Dermatology|May 16, 2017
Prognostic factors in mycosis fungoides: international advances in the validation of prognostic indicesJ J Scarisbrick
Clinical and Experimental Dermatology|February 19, 2000
Dermatology blues--Society of Investigative Dermatology 60th Annual Meeting, 5-9 May 1999, Chicago, USAJ J Scarisbrick
Presse Medicale (Paris, France : 1983)|May 1, 2022
The PROCLIPI international registry, an important tool to evaluate the prognosis of cutaneous T cell lymphomasJ J Scarisbrick
The British Journal of Dermatology|April 30, 2013
How big is your hand and should you use it to score skin in cutaneous T-cell lymphoma?J J Scarisbrick, S Morris
Journal of Steroid Biochemistry|January 1, 1975
Radioimmunoassay of progesterone: comparison of (1,2,6,7-3-H4)-progesterone and progesterone-(125-I)-iodohistamine radioligandsJ J Scarisbrick, E H Cameron
Clinical Chemistry|December 1, 1973
Radioimmunoassay of plasma progesteroneE H Cameron, J J Scarisbrick
Journal of Steroid Biochemistry|November 1, 1973
The determination of corticosterone concentration in rat plasma by competitive protein binding analysisE H Cameron, J J Scarisbrick
Pageof 6

Showing results (1-10 of 52) with videos related to

Sort By:
Pageof 6
Clinical and Experimental Dermatology|February 21, 2006
Staging and management of cutaneous T-cell lymphomaJ J Scarisbrick
The British Journal of Dermatology|January 10, 2018
Brentuximab vedotin is an effective therapy for CD30<sup>+</sup> mycosis fungoides and cutaneous anaplastic large-cell lymphoma: what is the cost?J J Scarisbrick
The British Journal of Dermatology|August 4, 2016
Cutaneous T-cell lymphomas: an urgent need for more improved therapiesJ J Scarisbrick
The British Journal of Dermatology|May 16, 2017
Prognostic factors in mycosis fungoides: international advances in the validation of prognostic indicesJ J Scarisbrick
Clinical and Experimental Dermatology|February 19, 2000
Dermatology blues--Society of Investigative Dermatology 60th Annual Meeting, 5-9 May 1999, Chicago, USAJ J Scarisbrick
Presse Medicale (Paris, France : 1983)|May 1, 2022
The PROCLIPI international registry, an important tool to evaluate the prognosis of cutaneous T cell lymphomasJ J Scarisbrick
The British Journal of Dermatology|April 30, 2013
How big is your hand and should you use it to score skin in cutaneous T-cell lymphoma?J J Scarisbrick, S Morris
Journal of Steroid Biochemistry|January 1, 1975
Radioimmunoassay of progesterone: comparison of (1,2,6,7-3-H4)-progesterone and progesterone-(125-I)-iodohistamine radioligandsJ J Scarisbrick, E H Cameron
Clinical Chemistry|December 1, 1973
Radioimmunoassay of plasma progesteroneE H Cameron, J J Scarisbrick
Journal of Steroid Biochemistry|November 1, 1973
The determination of corticosterone concentration in rat plasma by competitive protein binding analysisE H Cameron, J J Scarisbrick
Pageof 6